Introduction
Hantaviruses, negative-stranded RNA viruses belonging to the Bunyaviridae family, can cause severe disease in humans. Depending on the type of hantavirus, either haemorrhagic fever with renal syndrome (HFRS) or hantavirus cardiopulmonary syndrome may occur after inhalation of virus-containing aerosols [1] . HFRS is characterised by acute renal failure, fever (above 38.5 °C) and potentially accompanied by severe bleeding complications [2] ; it is a notifiable disease in the Netherlands. HFRS cases are found in large parts of Europe and Asia [3] . Pathogenic hantaviruses are rodent-borne and each of these viruses are spread by a specific rodent species. For the HFRS-causing hantaviruses, these include Apodemus, Myodes, Rattus and possibly Microtus species [4, 5] . The causative agent of HFRS known to be endemic in the Netherlands is Puumala virus (PUUV), which is spread by its chronically infected reservoir, the bank vole (Myodes glareolus) [6] . Symptomatic cases of PUUV infection may develop mild HFRS, often referred to as nephropathia epidemica. Recent reports describe PUUV infections with a broader clinical spectrum, ranging from mild febrile cases, without renal impairment or haemorrhage, to severe respiratory manifestations without any signs of renal involvement [7, 8] . Historically, the occurrence of PUUV infection in the Netherlands has been restricted to the eastern and southern parts of the country, with an incidence of 25-30 cases reported per year (approximately 0.04-0.18 cases per 100,000 population) [9] . Since 2007, several studies have described an increase in the number of human PUUV infections in neighbouring countries at the eastern (Germany) and southern borders (Belgium) [10] [11] [12] . To date, a similar increase in the number of human PUUV infections has not been observed in the Netherlands.
In the early 1990s, Groen et al. tested 8,892 sera obtained in the Netherlands from different risk groups, such as renal disease patients, and subjects from suspected occupational risk groups, such as forestry workers and military personnel, for the presence of hantavirus antibodies [13] . The highest prevalence (up to 6%) was seen in participants with known occupational risk factors associated with increased rodent exposure [13, 14] . Data (which are as yet unpublished but a summary of the main results is available) from a large serum bank study in the Netherlands that started in 2006 showed a hantavirus seroprevalence, in a cross-sectional population based study, of 1.7% [15] . Given that 70-80% of PUUV infections are asymptomatic and that only 5-10% of symptomatic patients will probably seek medical attention [16] , the 25-30 cases reported every year in the Netherlands (with a population of 16.8 million [17] ) are indicative of potential underdiagnosis of hantavirus infections [4, 5] . In 2011, we described a case report of a patient with nephropathia epidemica diagnosed outside the area known to be endemic for hantavirus circulation in the Netherlands, Overijssel [18] . Although the patient had visited a known PUUV-endemic area, this information in the patient history did not result in rapid diagnosis of the cause of the disease, illustrating unawareness of hantavirus infections.
Leptospira, a genus of helical-shaped bacteria, forms another important group of causative agents of rodentborne haemorrhagic fever in the Netherlands [19] . Pathogenic Leptospira cause leptospirosis, which shares many clinical manifestations with HFRS, such as renal failure, thrombocytopenia and potential bleeding complications [3] . Interestingly, two studies, from Italy and Sri Lanka, showed an increased hantavirus seroprevalence in patients suspected of having leptospirosis. Compared with control groups consisting of office personnel or healthy blood donors, the number of confirmed cases of hantavirus infection was significantly higher among those who were clinically suspected, by a clinician, of having leptospirosis [20, 21] . Groen et al. reported a hantavirus seroprevalence of about 1% in patients suspected of having acute leptospirosis in the Netherlands in samples collected between 1972 and 1994 [13] . The actual prevalence of confirmed acute leptospirosis was slightly higher (3%) [13] .
In the Netherlands, a relatively low number of leptospirosis cases are registered annually, as are HFRS cases, with a reported incidence of 0.25 leptospirosis cases/100,000 population [19] . To investigate the putative underdiagnosis of hantavirus infection in symptomatic patients, we tested a cohort of leptospirosis-suspected, but confirmed-negative, patients with no travel history for the previous three months, for the presence of hantavirus-specific antibodies, using a two-step strategy: pan-hantavirus enzyme-linked immunosorbent assays (ELISAs) followed by two separate immunofluorescence assays (IFA): one to detect PUUV serogroup antibodies and one to detect Hantaan virus (HNTV) serogroup antibodies (HNTV was used as it belongs to the same serogroup as Seoul hantavirus (SEOV). Recent evidence indicates the circulation of SEOV in Europe [22] [23] [24] , spread by Rattus norvegicus, which is also a well-known carrier of Leptospira [3] ). To confirm the ELISA and IFA results, focus reduction neutralisation tests (FRNTs) were used, the gold standard technique in hantavirus serology. All IFA IgM-positive sera were tested in the FRNT with PUUV virus. In addition, because recent evidence indicates the circulation of SEOV in Europe, we included SEOV, as well as Dobrava virus (DOBV), in the FRNT, although not the main aim of this study, to gain insight into the potential introduction of these viruses in the Netherlands.
Methods

Serum bank
Sera from non-travelling Dutch patients with a negative leptospirosis diagnosis -based on a microscopic agglutination test (MAT), ELISA and culture performed at the National Leptospirosis Reference laboratory (NRL) at the Royal Tropical Institute (KIT) in Amsterdam -were included in our study. A sample was deemed to be negative for leptospirosis if the patient did not meet the case definition for leptospirosis -i.e. the inhouse ELISA for leptospirosis was below the cut-off titre of 1:80 and the MAT showed no relevant titre of Leptospira-specfic antibodies (<1:160) [25] . The study cohort was taken from submissions of sera to the NRL in 2010, as a large increase in the number of PUUV infections in Germany and Belgium were observed that year [4] . In addition, we also included sera from patients meeting the above inclusion criteria that were received by the NRL during April to November 2011, the season for PUUV activity in northern and western Europe [26] ( Figure 1 ).
As we were interested in patients who had pan-hantavirus IgM antibodies, we selected patients whose samples had been collected at least two days after symptom onset, up to four weeks (28 days) after symptom onset. All samples were heat inactivated (30 minutes at 56 °C) and stored at −20 °C until testing. Requests for leptospirosis testing were accompanied by a standardised form with information about place of residence, travel history, presenting symptoms and occupation: these data were reviewed.
Hantavirus underdiagnosis was assessed by checking if testing for hantavirus was requested at either of the hantavirus diagnostic laboratories in the Netherlands (Erasmus MC in Rotterdam and RIVM in Bilthoven) for any of the pan-hantavirus ELISA-responsive sera (equivocal or positive result in an IgG or IgM ELISA).
Patients whose sera were responsive in any of the diagnostic tests were ranked by likelihood of hantavirus infection. Patients whose sera were positive in the IgM ELISA, IFA and FRNT were considered a confirmed case of acute hantavirus infection. If only the IgM ELISA was positive (or equivocal) and IFA was positive, the patient was considered a probable acute case. If only the IgG ELISA was positive and therefore IFA was not performed, but the FRNT was positive for PUUV, the patient was also considered a probable acute case. If only the IgM ELISA was positive or equivocal, the patient was considered not a case of hantavirus infection. An optical density (OD) of >1.10 was regarded as positive, between ≥0.90 and ≤1.10 as equivocal and <0.90 as negative.
Enzyme-linked immunosorbent assay
Immunofluorescence assay
ELISA IgM-positive or equivocal sera were tested in IFA by using commercial slides with PUUV-and HNTVinfected cells (PROGEN Biotechnik). Only IgM-reactive samples were chosen as these are indicative of a recent infection, possibly related to the clinical symptoms that were the basis of the initial request for leptospirosis testing. IFA was used because of its higher reported specificity and the possibility of being able to distinguish between PUUV-or HTNV-like serotype infections (manufacturer's insert, PROGEN Biotechnik). Before testing, the sera were incubated with liver acetone powder from calves (Sigma-Aldrich, Germany) to reduce background fluorescence. For the IgM test, the sera were pretreated with GullSORB (Meridian Bioscience Inc., United States) to reduce isotype competition. Sera were serially diluted twofold starting at 1:32 and incubated on the slides for 1 hour at 37 °C. After this step, the wells were incubated with either a fluorescein isothiocyanate (FITC)-labelled goat antihuman IgG or IgM conjugate. Fluorescence was scored under an immunofluorescence microscope. The cut-off titre for a positive result was defined as the sample dilution for which specific fluorescence was greater than the sample dilution for which specific fluorescence was just identifiable: in this study, it was >1:64. FRNTs for DOBV strain Slovenia, SEOV strain 80-39 and PUUV strain Kazaan were carried out as described elsewhere [27] . Diluted sera were mixed with an equal volume of diluted virus containing 30-70 focus-forming units/100 µl. The serum end-concentration was 1:40. The mixture was incubated at 37 °C for 1 hour and subsequently inoculated into wells of six-well tissue culture plates containing confluent Vero E6 cell monolayers. The wells were overlaid with a mixture of agarose and tissue culture medium and incubated for 7-13 days. The agarose was removed from the wells and the cells were fixed. For PUUV-infected cells, polyclonal macaque serum [28] was used as the primary antibody and the monoclonal antibody 1C12 for DOBV-and SEOV-infected cells as described elsewhere [29] . This step was followed by adding peroxidaselabelled goat-anti-human IgG for the macaque serum and goat-anti-mouse IgG for the 1C12 monoclonal antibody to the cells, to indicate virus-infected cells.
Focus reduction neutralisation test
Tetramethylbenzidine was used as substrate and foci were counted. An 80% reduction in the number of foci, compared with the virus control, was used as the criterion for virus neutralisation titres.
Review of hantavirus diagnostic requests carried out during suspicion of leptospirosis at the time of sampling
All samples responsive in the IgM and/or IgG pan-hantavirus ELISA were checked for patient-specific characteristics (sex and date of birth). The combination of sex and date of birth was checked in the databases of the hantavirus diagnostic laboratories in the Netherlands. If the sample combination matched the information from the database and the diagnostic request was made in 2010 or 2011, the patient was scored as having been adequately diagnosed for hantavirus disease during the onset of their symptoms. If the sex and date of birth combination could not be found in the databases, but the patient's sample was reactive in any of our tests, the case was scored as a missed probable or confirmed hantavirus case, as described in the serum bank section above.
Ethical issues
This study was exempted from ethical review of human subject research by the Medical Ethical Review Committee of the Erasmus MC Medical Centre, University of Rotterdam. All data have been anonymised and are not attributable to individual patients.
Results
Enzyme-linked immunosorbent assay and immunofluorescence assay serology
Of the 1,262 samples received for leptospirosis diagnostic testing during January-December 2010 and April-November 2011, 861 were excluded, as the patients did not meet the inclusion criteria of our study. 
Confirmation by focus reduction neutralisation test
FRNT was performed on eight of the nine sera with a positive IgM response in the PUUV IFA (there was an insufficient amount of serum in the ninth sample). It confirmed that seven of the eight samples tested were from patients with recent PUUV infections (samples 4, 7, 10, 11, 12, 19 and 22) ( Table 1) .
We also tested the two sera with an HNTV IgM-positive IFA and a positive or equivocal ELISA IgM response (samples 5 and 6): both sera were negative by FRNT.
To test if cases had been missed due to lack of sensitivity of the IFAs, we selected eight samples, of which seven samples had enough serum left for FRNT, with only IgM reactivity in the ELISAs and a negative PUUV or HNTV IFA (samples 2, 3, 13, 15, 17, 18 and 20): all seven samples were negative by FRNT.
We also selected three samples that had not been included in the IFA analysis (as they were ELISA IgM negative), but that tested positive in the IgG ELISA (Cases 1,8 and 16 ). These samples were tested by FRNT because there was a high degree of suspicion of PUUV infection based on the application form for leptospirosis diagnostic request sent by the clinician (e.g. recorded renal failure and possible rodent exposure). All three patients had a long duration of their complaints (more than three weeks since symptom onset, making it possible that hantavirus disease, without the detection of IgM antibodies, was the cause of their symptoms. All three were positive in the PUUV FRNT.
Thus in total, FRNT for PUUV, SEOV and DOBV was performed on 20 of the 22 selected samples, due to an insufficient amount of serum in two samples. Of the 20 serum samples tested, 10 were confirmed as PUUV positive, seven of which were considered due to a recent infection, based on the presence of IgM antibodies.
Patient characteristics and registered clinical signs and symptoms in confirmed cases
Because of the retrospective nature of our study, we could confirm if patients had been adequately tested for hantavirus infection during their disease course or if the patient was a missed case of PUUV infection. Of the 27 samples with at least an equivocal response in the IgM ELISA in our study, which would necessitate further testing of a follow-up serum sample, four were adequately tested by routine serology for hantavirus infection at diagnostic centres at the time of sampling during suspicion of leptospirosis (samples 4, 10, 11 and 12).
The two samples that were responsive in the ELISAs and HNTV IFA, but not in FRNT (samples 5 and 6), were not tested for hantavirus antibodies by ELISA or IFA at the time the patients were sampled.
All available information from retroactively determined probable or confirmed cases of hantavirus infection that were not tested for hantavirus infection during suspicion of leptospirosis at the time of sampling is shown in Table 2 . In general, most of the cases were in the eastern parts of the Netherlands. Newly recognised areas with confirmed cases were in the northern province of Groningen and the western province 
Discussion
In the samples tested, a positive response of hantavirus IgM antibodies in the ELISA was observed in 4.3% (11/255) of samples taken in 2010 and 4.1% (6/146) of the samples taken in 2011. When including samples with an equivocal ELISA result, the overall percentage with an IgM response was 6.7% (27/401) . Confirmation with IFA IgM resulted in a 2.7% (11/401) seropositivity in the cohort. Of these 11 samples, seven were confirmed by FRNT, corresponding to an overall seropositivity in the cohort of almost 2%. However, this percentage could very well be an underestimation. For instance, one sample could not be confirmed by FRNT due to a lack of available serum after ELISA and IFA screening. It is conceivable that in our cohort of symptomatic patients, of the seven confirmed hantavirus diagnoses, at least three cases were not adequately diagnosed at the time of disease (Cases 7, 19 and 22) . The other four confirmed cases were found in the databases of the hantavirus diagnostic centres in the Netherlands, and thus were adequately diagnosed at the time of disease. We also identified seven probable cases of acute hantavirus infection: we consider that hantavirus infection was a highly plausible explanation for their symptoms, but either FRNT confirmation was not performed due to the lack of serum or the presence of IgM antibodies (confirming acute infection) could not be proved by ELISA and IFA.
All samples confirmed by FRNT (n=10) only showed PUUV-neutralising activity. The vector of this hantavirus is Myodes glareoulus (bank vole), a small, reddish rodent that inhabits large parts of the Netherlands, solely in grasslands and forests [9] . Case 6, with high OD values in IgM and IgG ELISA screening and a positive HNTV IFA, did not neutralise PUUV, DOBV or SEOV.
This study revealed a high seroprevalence of about 2% of hantavirus antibodies in a cohort of leptospirosissuspected patients who tested negative for leptospirosis. Leptospirosis in the Netherlands may be either endemic or imported [19] . In our cohort, travel history was well documented and hence we consider it quite certain that the patients we studied contracted hantaviruses in the Netherlands. This cohort also gave us the opportunity to study the circulation of hantaviruses other than PUUV in The Netherlands. It is important to monitor this, since evidence is mounting of an increase in the number of SEOV infections in Europe and worldwide, with a recent case reported in the United Kingdom [30] . However, in the samples tested from the Netherlands, the SEOV FRNT was negative. Results were also not indicative for infections with DOBV, which is vectored by the yellownecked mouse (Apodemus flavicollis). It is possible that the ELISA and IFA results in samples 5 and 6 were false positives. The specificity of the ELISA and IFA is below 100%, resulting in a (small) chance of crossreactivity. Test specifications of the ELISA test showed no known cross-reactive pathogens, but this presumption is based on results from very small serum cohorts (manufacturer's insert). Although SEOV and DOBV have been excluded as the causative agents in our study, the remaining hantaviruses in the HNTV serogroup are vectored by reservoir species not known to be present in the Netherlands. Thus, while we cannot rule out the possibility that other hantaviruses from the HNTV serogroup caused the disease in patients from whom samples 5 and 6 were obtained, with no travel history, this remains highly unlikely.
Our results show quite a large discrepancy between the initial ELISA screening, followed by IFA analysis and eventual gold standard FRNT confirmation. Samples that tested positive only in the IgM ELISA (n=7) were not confirmed positive by FRNT. In most cases (7/9), a positive response in the IgM pan-hantavirus ELISA in combination with a positive result in the PUUV IgM IFA was later confirmed by FRNT (sample 14 tested negative in the FRNT and sample 21 could not be tested). Therefore, we underline the importance of FRNT validation in epidemiological studies before drawing any major conclusions, particularly since hantavirus serology is highly prone to giving false-positive results [31] .
Acute leptospirosis and HFRS share many clinical manifestations and certain epidemiological features. Exposure to rodents is a known risk factor for both diseases. Hallmark symptoms in both HFRS and leptospirosis include kidney failure. Two of the four cases who were diagnosed at the time of their disease course had documented kidney disorders (data not shown). However, of the 10 cases who were not diagnosed, only one (sample 16) had documented kidney failure. Of the other nine undiagnosed cases, one was described as having 'high fever' (sample 7), two as having 'severe disease' (samples 1 and 7) and one as 'clinical picture not understood' (sample 22): the fact that these cases were undiagnosed in the Netherlands during their disease course could be due to a potential lack of typical presenting symptoms for hantavirus disease in the Netherlands, meaning the absence of kidney failure. Hepatic involvement, often present in leptospirosisone of the classic triads in Weil's disease [3] -could lead a clinician to think of leptospirosis, while not considering PUUV infection: this would have applied to the patient with hepatitis (sample 16), a probable case of acute hantavirus infection in our study. Atypical presentation of HFRS, as seen in some of the cases listed in Table 2 (samples 21 and 19) , has been the subject of several recent case reports [7, 32, 33] . However, unawareness and/or lack of clinicians' knowledge of how to recognise hantavirus disease could also be a reason for underdiagnosis.
Cases may also be underdiagnosed if the patients are outside the hantavirus-endemic area in the Netherlands. Such cases might not be identified due to the low, but clinically important number of infections, resulting in lack of awareness of the clinicians in these areas. If we compare the distribution of the previously undiagnosed cases in our cohort with the earlier serological data, for instance, data published by Groen et al. [14] , 7 of 10 cases of hantavirus infection not tested at the time of sampling for hantavirus disease (listed in Table 2 ) were from outside the known endemic area. Our conclusions regarding underdiagnosis are supported by a recent study showing 1.7% hantavirus seroprevalence in the Dutch population, which should lead to more symptomatic cases than the 25-30 cases reported annually [15] .
In this relatively small cohort with specific clinical indications for leptospirosis diagnostics, we have shown the presence of undiagnosed hantavirus cases. Leptospirosis itself is potentially an often-missed diagnosis in the Netherlands, due to unawareness [19] . It is conceivable that physicians, who do not include leptospirosis in their differential diagnosis, are even less aware of the possibility of hantavirus infections. Vice versa, it cannot be excluded that clinicians who are aware of hantavirus infections might miss potential leptospirosis. This hypothesis could be validated by performing larger-scale serological studies with broader cohorts, comprising patients who are suspected of having leptospirosis or hantavirus infection.
On the basis of the results in this paper, we feel it is important to increase awareness of hantavirus infection in the Netherlands. The increased incidence of hantavirus infections in Europe in recent years makes this even more important. This increase is affected by a multitude of factors. Some, such as changes in landscape architecture (e.g. (de)forestation, fragmentation of land by motorways, railways and agriculture and available burrow space) and increased food availability for the rodent reservoirs, are beneficial for the spread of hantaviruses [12] . The introduction or discovery of new hantavirus strains in Europe has been documented [23] and presents another major concern, necessitating epidemiological monitoring of vectors and patients. We advise that hantavirus and leptospirosis diagnostics should be considered for every patient with an undifferentiated fever in any area with potential rodent-borne infections, including typing of the causative agents if the results are positive.
By decreasing the unnecessary use of antibiotics [34] and providing clinicians with an accurate prediction of the disease course and a choice of adequate biomarkers of disease severity [3] , the identification of hantavirus infections might have a limited, but important, clinical importance. Furthermore, adequately diagnosing and typing hantavirus infections is of major public health importance in order to correctly identify and educate risk groups and to design tailor-made prevention programmes, such as rodent-control programmes and changes to landscape architecture.
